Company / R&D Expense
Theriva Biologics, Inc. R&D Expense History
FY2011-FY2011 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.6M
FY2011
5-year range
$1.6M / $1.6M
FY2011-FY2011
Trend
-
vs FY2010
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$2M in FY2011.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.80 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2011 | $1.6M | - |
As of FY2011 · SEC 10-K · Updated Jun 24, 2026